Spanish Grifols procures plasma assets from Green Cross for $460m

grifols

Spanish pharmaceutical company Grifols announced it has acquired plasma assets in North America for $460 million.

Grifols will buy a plasma fractionation plant in Canada and two purification facilities and 11 plasma collection centres in the United States, the company said in a statement.The Barcelona-based firm will need no new financing to carry out the acquisition, it said.

Grifols is one of the world’s top producers of treatments based on human plasma.

myfisense

myfisense


Leave a Reply

Your email address will not be published. Required fields are marked *

FI Sense

FREE
VIEW